Key result
China-manufactured pulsed field ablation devices are emerging as technically distinct, economically competitive, and clinically viable alternatives to Western systems.
Answers are grounded in this paper and cite their sources.
The rapid development and indigenisation of Chinese PFA systems offer an effective, low-cost solution for AF ablation, challenging the historical market dominance of Western medical device manufacturers.
The history of catheter ablation for atrial fibrillation (AF) is, in many ways, a history of energy.From the early days of direct-current shock to the refinement of radiofrequency thermal energy, and then to the cryoballoon, each epoch has been defined by the modality through which we seek to electrically silence the pulmonary veins, empirically.We now stand at the threshold of another such epoch-pulsed field ablation (PFA)-and what is striking about this moment is not merely the strategy and physics of irreversible electroporation, but the efforts of its manufacture.For the first time in the history of cardiac electrophysiology, a disruptive technology is being developed, refined, and brought to market at scale not only in Minneapolis, Haifa, and Boston, but also in Shenzhen, Chengdu, and Shanghai.This is indigenisation, and it matters profoundly to the global electrophysiology community.
No takes yet. Share an insight, caveat, or question.
Yan Yao (2026) conducted an editorial in Atrial fibrillation. China-manufactured pulsed field ablation (PFA) devices vs. Western PFA systems was evaluated. China-manufactured pulsed field ablation devices are emerging as technically distinct, economically competitive, and clinically viable alternatives to Western systems.
Synapse has enriched 10 related papers. Consider them for comparative context: